ArticleIn vivo (Athens, Greece)
Psychometric Evaluation of Patients With Vitiligo.
Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimVitiligo is a chronic acquired pigmentary disorder with substantial psychosocial consequences. This study evaluated depression, general psychopathology, personality traits, hostility, and dermatology-related quality of life in patients with vitiligo, and examined the demographic and clinical factors associated with psychological burden and impaired social functioning. PATIENTS AND
methodsA cross-sectional study was conducted in 100 patients with vitiligo followed at Andreas Syggros Hospital, Athens, Greece. Participants completed a sociodemographic questionnaire, the Beck Depression Inventory (BDI), Symptom Checklist-90-Revised (SCL-90-R), Eysenck Personality Questionnaire (EPQ), Hostility and Direction of Hostility Questionnaire (HDHQ), and Dermatology Life Quality Index (DLQI). Non-parametric tests, correlation analyses, and multivariable logistic and binomial regression models were applied.
resultsMost patients reported minimal depressive symptoms, although more than one-third showed mild-to-severe depressive burden. Psychological distress was mainly reflected in anxiety, depression, somatization, and interpersonal sensitivity. Women and patients with comorbidities had significantly higher depression scores and poorer quality of life. Lesion localization was clinically relevant: trunk, genital, and lower-extremity involvement were associated with greater psychological burden and worse DLQI scores, whereas facial involvement was associated with lower psychopathology scores in multivariable analysis. Depression was independently associated with comorbidity, neuroticism, psychoticism, and self-criticism. Impaired quality of life was associated with female sex, extremity involvement, and self-criticism, while longer disease duration showed a protective effect.
conclusionVitiligo is a multidimensional disorder in which dermatological, psychological, and social factors interact closely. Quality of life is influenced more strongly by psychological status and personality-related factors than by disease severity alone, supporting the need for interdisciplinary management that integrates dermatologic and mental health care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.